Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025.

Aware of the specific health challenges in each territory, we adapt our offerings to meet the needs of breeders and veterinarians. As of April 2025, our new combined vaccine against porcine parvovirus and leptospirosis is available in France, where both diseases pose significant health challenges.

Ten years after its launch, our Veterinary HPM^® physiological food range is getting a makeover to better meet the evolving expectations of veterinarians and pet owners. Our commitment, however, remains the same: to advance animal health through high-quality nutrition, based on science and innovation.